Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 1,079,137 | 1,023,851 | 777,738 | 648,597 | 629,290 |
| Cost of Goods | 529,602 | 416,002 | 308,389 | 269,898 | 285,702 |
| Gross Profit | 703,220 | 607,840 | 469,340 | 378,690 | 343,580 |
| Operating Expenses | 537,468 | 471,252 | 378,900 | 311,061 | 494,893 |
| Operating Income | 12,669 | 136,599 | 90,838 | 68,536 | -150,603 |
| Interest Expense | 33,977 | 32,203 | 28,561 | 24,097 | 11,295 |
| Other Income | 180,843 | 16,980 | 22,791 | 26,737 | 24,617 |
| Pre-tax Income | 159,535 | 121,376 | 85,068 | 71,176 | -137,281 |
| Income Tax | 38,050 | 32,551 | 24,329 | 22,207 | 9,338 |
| Net Income Continuous | 121,485 | 88,825 | 60,139 | 47,669 | -147,659 |
| Net Income Discontinuous | 10,561 | 0 | 0 | 0 | 0 |
| Net Income | $132,046 | $88,825 | $60,130 | $47,667 | $-147,666 |
| EBITDA(a) | $183,509 | $296,389 | $218,118 | $159,586 | $138,547 |